Blueprint Medicines Corp (DELISTED) (BPMC:DL)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Jul 28, 16:00
Blueprint Medicines EPS Diluted (Quarterly): 0.0075 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| TG Therapeutics, Inc. | 2.428 |
| AVITA Medical, Inc. | -0.4644 |
| Ardelyx, Inc. | -0.004 |
| Bristol Myers Squibb Co. | 1.079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.496M |
| Revenue (Quarterly) | 149.41M |
| Total Expenses (Quarterly) | 148.92M |
| Enterprise Value | 8.172B |
| Gross Profit Margin (Quarterly) | 98.12% |
| Profit Margin (Quarterly) | 0.33% |
| Earnings Yield | -1.91% |
| Normalized Earnings Yield | -1.908 |